RLS Therapeutics

About:

Pharmaceutical development company located in Nashville, TN.

Website: http://www.RLSTherapeutics.com

Description:

RLS Therapeutics is creating a novel small molecule therapeutic to treat a wide spectrum of disease states rooted in inflammation and cellular dysfunction processes in both animals and humans. Strong and compelling anecdotal data has led to the creation of several variants of the lead molecule. Our current lead drug candidate is focused on the treatment of neurodegenerative disease.

Total Funding Amount:

$1.37M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Nashville, Tennessee, United States

Founded Date:

2016-01-01

Contact Email:

mhenschen(AT)relaylifescience.com

Founders:

Jim Monsor, Marcus Henschen

Number of Employees:

1-10

Last Funding Date:

2019-11-01

IPO Status:

Private

Industries:

© 2025 bioDAO.ai